ENTITY
SMARTSCORE: 2.6/5

Cingulate (CING US)

6
Analysis
Health Care • United States
Cingulate Inc. operates as a clinical stage biopharmaceutical company. The Company develops pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.
more
News Icon
No news found
We’ll display news we find for Cingulate here
x